Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people.

Learn more› By The Deals Team The Deals team hunts for and highlights only the best discounts on picks made by our editorial ...

Discover the four key trends and innovations driving infusion therapy for chronic diseases as we head into 2025. Stay informed and up-to-date on the latest advancements in healthcare.

AbbVie has launched its Produodopa for Parkinson’s in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the disease.